drugset / Trial / NCT02753803
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
RandomizedCrossoverOpen-labelHealth-services research
Summary
A randomized, open-label, multiple dosing, three-way crossover clinical trial to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of evogliptin 5 mg and pioglitazone 30 mg after oral administration in healthy male subjects
Timeline
- Start
- 2016-07-27
- Primary completion
- 2016-10-19
- Completion
- 2017-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evogliptin | Small molecule | 5 mg | Oral |
| Subject | Pioglitazone | Small molecule | 30 mg | Oral |